June 2, 2020

Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets

First enzymes will target NGS-based diagnostics, RNA-directed viral diagnostics and RNA manufacturing REDWOOD CITY, Calif. and JUPITER, Fla., June 01, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. […]
June 2, 2020

Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology

SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ — Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement […]
June 1, 2020

Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., June 1, 2020 /PRNewswire/ — Regeneron and Intellia to co-develop potential hemophilia A and B treatments using their jointly-owned targeted transgene insertion capabilities Regeneron gains […]
June 1, 2020

Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors

– SYNB1891 is currently being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors or lymphoma – CAMBRIDGE, Mass., June 1, 2020 /PRNewswire/ — Synlogic, […]
May 30, 2020

Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research

With extended applications, Tapestri Designer, the only AI-powered cloud-based tool for single-cell panel designs, will improve drug development and CRISPR quality control studies South San Francisco, […]
May 30, 2020

LexaGene Places Pre-Commercial Instrument for COVID-19 Testing

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory BEVERLY, Mass. – May 28, 2020 –  LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”) […]
May 30, 2020

FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test

INDIANAPOLIS, May 28, 2020 /PRNewswire/ — Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease […]
May 28, 2020
Ginkgo Bioworks

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing BOSTON, May 28, 2020 /PRNewswire/ — Today, Ginkgo Bioworks is announcing a $70MM investment from Illumina (Nasdaq: ILMN) and existing […]
May 27, 2020

Renaissance BioScience Corp. to receive R&D funding to advance its yeast-based RNAi biopesticide and biotherapeutics technology

Vancouver, Canada — May 26, 2020 — Renaissance BioScience Corp. (RBSC), a leading global bioengineering company, is pleased to announce that it will receive advisory services […]
May 23, 2020

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

AbCellera will use its world-leading antibody drug discovery platform in a multi-year collaboration to identify antibodies against up to nine targets May 22, 2020 05:28 PM […]